Astellas Pharma Inc.
[WKN: 856273 | ISIN: JP3942400007]
Aktienkurse
8,417€ -3,36%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid: Ask:

Echtzeit-Chart der Astellas Pharma Inc. Aktie

Astellas Pharma Inc. Chart

Charttool öffnen

Börsenkurse Astellas Pharma Inc.

Börse Stuttgart - - - - 8,417€ -2,08%
Börse Frankfurt - - - - 8,249€ -1,82%
gettex - - - - 8,403€ -3,24%
Tradegate - - - - 8,319€ -4,30%
Lang & Schwarz - - - - 8,347€ -3,71%
Echtzeit Euro - - - - 8,417€ -3,36%

Profil der Astellas Pharma Inc. Aktie

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.